Organized by major drug classes, it offers comprehensive data on dosage, side effects, drug-drug interactions, withdrawal, and more everything clinicians need to know to properly manage their clients pharmacological treatment."

Get a quick, expert overview of the key issues surrounding best practices and current consensus on major depressive disorder (MDD). This concise resource by Drs. Roger S. McIntyre, Carola Rong, Mehala Subramaniapillai, and Yena Lee consolidates today's available information on this complex topic into one convenient resource, making it an ideal, easy-to-digest reference for both psychiatrists and primary care physicians. Get a quick, expert overview of the key issues surrounding best practices and current consensus on major depressive disorder (MDD). This concise resource by Drs. Roger S. McIntyre, Carola Rong, Mehala Subramaniapillai, and Yena Lee consolidates today's available information on this complex topic into one convenient resource, making it an ideal, easy-to-digest reference for both psychiatrists and primary care physicians.

Major depressive disorder (MDD) is the leading cause of disability globally in both developed and developing nations. The staggering economic costs attributable to MDD are largely a consequence of impairment in role function. Evidence indicates that disturbance in the domain of cognitive function in individuals with MDD is the principal determinant of health outcome. This is the first book to comprehensively explore the domain of cognition in MDD. The literature describing cognitive dysfunction is reviewed with particular focus on clinical determinants, pathophysiology and causative factors. The patient subpopulations most susceptible are defined. A summary of contemporary assessment tools for research and clinical purposes is provided. Multimodality treatments and prevention strategies are described. This book is an invaluable resource for psychiatrists, neuropsychologists and other members of the mental health team, as well as for policy makers, vocation rehabilitation experts, disability providers and other stakeholders interested in improving health outcomes in MDD.

This book address metabolic disorders (e.g. diabetes mellitus, dyslipidemia, overweight/obesity, disturbances in inflammatory response systems) and specifically their prevalence, mediating and moderating variables, implications for psychiatric/medical outcome, endophenotypic research, neurocognition and patient management. It is a concise relevant synthesis of extensive literature describing both pre-clinical and clinical research which scrutinises the interface between mental disorders, and both normal, and abnormal metabolic processes.

The volume presents the most important and practical information to prescribe lithium, valproate, carbamazepine and other anticonvulsants in psychiatric practice safely and successfully. The information is ready to use and easy to remember and is focused primarily on clinically relevant issues such as preliminary laboratory evaluations, drug dosages, schedules, indications, contraindications, side effects and strategies to manage them. Clinical cases and clinical pearls are provided for each medication. The volume outlines the best strategies to choose psychotropic medications skillfully. The book will be an invaluable reference for psychiatric residents and any other health care practitioner seeking for a tool that is simple, concise and immediately useful for everyday clinical practice.